The 2021 SPAC moment: what we got right and wrong

The best snapshot of 2021 is not a chart. It is a two-week burst in February. Jazz Pharmaceuticals acquires GW Pharmaceuticals, Electronic Arts acquires Glu Mobile, Tyler Technologies acquires NIC and V99 acquires Telenav all landed within days of each other. Some were all-cash. Some mixed cash and shares. All carried the same underlying message: buyers believed capital was available, multiples were generous and waiting was a bigger risk than paying up.

Exit Mode's view is that 2021 was the year founders and boards started to mistake a hot market for a permanent condition. The SPAC boom mattered because it set the emotional temperature of the whole cycle, even in deals that had nothing to do with a SPAC structure. Public listings looked easier than they were. Equity looked safer than it was. Strategic buyers acted fast because they feared missing assets in a market where everything seemed to be re-rated upward at once. Some of that logic was rational. Some of it aged badly. The lasting lesson is that bull markets do not only inflate valuations. They also distort founder judgement about what kind of company should be public, what kind should sell and how much of the consideration should be trusted.

Peak-market confidence still paid in cash

One of the simplest myths about 2021 is that it was all paper wealth. It was not. The year also produced buyers willing to pay real cash for assets they wanted to own outright. Electronic Arts acquires Glu Mobile, Tyler Technologies acquires NIC and V99 acquires Telenav were all-cash moves in technology. DiaSorin acquires Luminex did the same in healthcare.

That matters because it shows what buyers actually trusted at the top of the cycle. When an acquirer pays cash in a euphoric market, it is saying the asset is useful enough to own without hedging through seller paper. In 2021, the strongest assets still attracted hard-currency conviction. Founders should remember that when markets run hot. A high headline number is not always the best signal. A serious buyer offering clean cash is often telling the truth about value more clearly than a noisier public-market alternative.

The market treated equity like money

At the same time, 2021 normalised the idea that equity could do almost anything. Jazz Pharmaceuticals acquires GW Pharmaceuticals mixed cash and shares in a cross-border take-private. Sysorex acquires TTM Digital Assets & Technologies relied entirely on shares. APi Group acquires Chubb Limited used cash and loan notes. Each structure reflected a market that was comfortable pushing some of the value debate into future paper.

That was the deeper SPAC-era lesson. Founders saw listed equity trading at ambitious multiples and started to treat it as a stable store of value. It was not. Mixed consideration can be sensible when both sides genuinely want alignment. In 2021 it often carried a second meaning: the market was rich enough that buyers could preserve cash and still persuade sellers to ride along. That works until the cycle turns. Once multiples compress, the seller realises that "alignment" may just have been delayed price risk wearing a prettier label.

Regulators did not disappear just because markets were hot

Another mistake from 2021 was believing that speed in capital markets made the real-world closing path easier. Cellnex acquires CK Hutchison Networks Europe Investments sat in review. Jazz Pharmaceuticals acquires GW Pharmaceuticals had to bridge a UK-Irish structure in a regulated sector. DiaSorin acquires Luminex showed that even cash certainty does not erase regulatory work in healthcare.

The point is simple. A hot market can make boards braver, but it does not make regulators softer. In 2021, too many founders extrapolated from rich valuations and easy financing to assume every exit path had become easier. It had not. The buyer still had to clear jurisdictional reviews, change-of-control mechanics and integration risk. Bull-market confidence can hide those frictions during the pitch. It cannot remove them at completion.

By year-end, the tone had already changed

The late-year deals are a useful corrective to the myth that 2021 was one continuous party. RingCentral acquires Mitel US Holdings used cash and shares, preserving flexibility rather than forcing a clean-cash finish. Daybreak Oil and Gas acquires Reabold California was a share-for-share exchange with no cash disclosed. Those structures look different from the February burst for a reason. By the end of the year, buyers were already showing more caution in how they funded growth and how much risk they wanted sellers to retain.

This is the part many founders got wrong in real time. Peak conditions almost never end with a loud bell. They decay through structure first. Cash gives way to paper. Paper becomes more conditional. Buyers still do deals, but they stop underwriting the whole story themselves. By the time founders notice that shift, they are often negotiating in a colder market than the one that shaped their expectations.

The pattern

The common thread across 2021 is not simply exuberance. It is overconfidence in durability. The year got one thing right: strategic assets really were worth moving fast for. It got another thing wrong: it assumed exit conditions that felt easy in one quarter would stay easy for several more. Founders who treated the market as temporary did better than founders who treated it as normal.

Founder's Lens

Adam J. Graham's read on this year: I remember 2021 as the year a lot of smart founders started believing their paper valuation had become a fact. That was the trap. Great businesses still sold well, and some buyers made very rational moves, but too many boards confused a liquidity window with a permanent upgrade in company quality. Looking back from 2026, the founders who handled that year best were the ones who either took the clean exit on offer or raised capital with enough humility to survive the re-pricing that came after.

What it means today

The 2021 lesson is not "never trust a bull market." It is "do not build your exit plan on the assumption that the market owes you another year." If a buyer offers clean terms at the top of the cycle, weigh them against the real risk of paper consideration and public-market exposure. If you want the weekly read on how those shifts show up before the headlines catch up, that is what Insider is for.